Cochrane Hypertension
@cochranehtn.bsky.social
Based @UBC, we prepare/maintain/disseminate #SysRevs of effects of healthcare interventions for high blood pressure.
hypertension.cochrane.org Newsltr: http://eepurl.com/G2yC1
hypertension.cochrane.org Newsltr: http://eepurl.com/G2yC1
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
October 15, 2025 at 3:56 PM
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
🆕Review update🆕
Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10....
In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10....
In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
October 15, 2025 at 3:55 PM
🆕Review update🆕
Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10....
In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10....
In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
ICYMI - Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
September 2, 2025 at 5:51 PM
ICYMI - Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
June 10, 2025 at 8:11 PM
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
May 12, 2025 at 6:09 PM
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
🆕 We've published a new Cochrane #SystematicReview protocol:
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...
April 21, 2025 at 8:42 PM
🆕 We've published a new Cochrane #SystematicReview protocol:
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...
🚨Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
April 11, 2025 at 8:42 PM
🚨Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
🆕 Cochrane #SystematicReview 🆕
Effect of adrenergic agonist oral #decongestants on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
Effect of adrenergic agonist oral #decongestants on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
April 1, 2025 at 3:52 PM
🆕 Cochrane #SystematicReview 🆕
Effect of adrenergic agonist oral #decongestants on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
Effect of adrenergic agonist oral #decongestants on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
🆕 Cochrane #SystematicReview 🆕
Effect of #amphetamines on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
Effect of #amphetamines on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
March 31, 2025 at 7:16 PM
🆕 Cochrane #SystematicReview 🆕
Effect of #amphetamines on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
Effect of #amphetamines on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
ICYMI - Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
March 24, 2025 at 4:36 PM
ICYMI - Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
🚨ICYMI - Cochrane #SystematicReview
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
March 12, 2025 at 6:29 PM
🚨ICYMI - Cochrane #SystematicReview
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/14651858.CD012570.pub2
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/14651858.CD012570.pub2
#CochraneEvidence #Blogshot
March 4, 2025 at 8:31 PM
Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/14651858.CD012570.pub2
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/14651858.CD012570.pub2
#CochraneEvidence #Blogshot
🎺 Cochrane #SystematicReview 🚨
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
tinyurl.com/renin-arb-htn
#CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
tinyurl.com/renin-arb-htn
#CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social
February 28, 2025 at 7:25 PM
🎺 Cochrane #SystematicReview 🚨
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
tinyurl.com/renin-arb-htn
#CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
tinyurl.com/renin-arb-htn
#CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social
🎺 Cochrane #SystematicReview 🚨
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
February 27, 2025 at 11:17 PM
🎺 Cochrane #SystematicReview 🚨
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
🆕 Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence
February 27, 2025 at 8:54 PM
🆕 Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence
🆕 #BestEvidence webinar recording
Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives:
⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety
#drugevidence24 #meded #medsafety
Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives:
⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety
#drugevidence24 #meded #medsafety
February 24, 2025 at 5:59 PM
🆕 #BestEvidence webinar recording
Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives:
⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety
#drugevidence24 #meded #medsafety
Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives:
⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety
#drugevidence24 #meded #medsafety
ICYMI - For people with high #bloodpressure (BP) & chronic renal disease, evidence does NOT support lower than standard BP targets 🎯
Our #Cochrane review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r...
#SystematicReview #hypertension #medsky #pharmsky
Our #Cochrane review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r...
#SystematicReview #hypertension #medsky #pharmsky
December 3, 2024 at 5:42 PM
ICYMI - For people with high #bloodpressure (BP) & chronic renal disease, evidence does NOT support lower than standard BP targets 🎯
Our #Cochrane review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r...
#SystematicReview #hypertension #medsky #pharmsky
Our #Cochrane review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r...
#SystematicReview #hypertension #medsky #pharmsky
ICYMI - hypertension #systematicreview
Our Cochrane Library review on evening vs morning dosing considers evidence from 25 studies that randomised more than 3,000 people: tiny.cc/pm-am-htn
#researchsky #prescribing #HighBloodPressure #medsky
Our Cochrane Library review on evening vs morning dosing considers evidence from 25 studies that randomised more than 3,000 people: tiny.cc/pm-am-htn
#researchsky #prescribing #HighBloodPressure #medsky
November 19, 2024 at 6:57 PM
ICYMI - hypertension #systematicreview
Our Cochrane Library review on evening vs morning dosing considers evidence from 25 studies that randomised more than 3,000 people: tiny.cc/pm-am-htn
#researchsky #prescribing #HighBloodPressure #medsky
Our Cochrane Library review on evening vs morning dosing considers evidence from 25 studies that randomised more than 3,000 people: tiny.cc/pm-am-htn
#researchsky #prescribing #HighBloodPressure #medsky
🎺 For people with high #bloodpressure (BP) & chronic renal disease, evidence does NOT support lower than standard BP targets 🎯
Our #Cochrane systematic review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r...
#SystematicReview #hypertension
Our #Cochrane systematic review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r...
#SystematicReview #hypertension
November 14, 2024 at 12:55 AM
🎺 For people with high #bloodpressure (BP) & chronic renal disease, evidence does NOT support lower than standard BP targets 🎯
Our #Cochrane systematic review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r...
#SystematicReview #hypertension
Our #Cochrane systematic review looks at evidence from 6 trials involving 7,348 participants: tinyurl.com/BP-targets-r...
#SystematicReview #hypertension